New pentacyclic guanidine alkaloids, normonanchocidins A, B and D (1-3) along with the earlier known monanchocidin A were isolated from the Far-Eastern marine sponge Monanchora pulchra. Structures of 1-3 were elucidated using 1D-and 2D-NMR spectroscopic and mass spectrometric data. Compound 1 and a mixture of 2 and 3 (1:1) exhibited cytotoxic activities against human leukemia THP-1 cells with IC 50 values of 2.1 µM and 3.7 µM, respectively, and against cervix epithelial carcinoma HeLa cells with IC 50 of 3.8 µM and 6.8 µM, respectively.
Pentacyclic guanidine alkaloids from the Far-Eastern marine sponge
Monanchora pulchra have unusual structures and high biological activities [1] [2] [3] [4] [5] . These alkaloids contain two different types of "anchor" fragments of morpholinone and spermidine types as in monanchocidins A-E [1, 2] and in monanchomycalins A-C, and ptilomycalin A [3, 4] , respectively. In continuation of our search for bioactive natural products from different collections of M. pulchra [1] [2] [3] [4] [5] [6] [7] [8] , herein we report the isolation of three new pentacyclic guanidine alkaloids with the third type of "anchor" from the sponge collected near Urup Island (45°55,1 N; 149°41.6 E; depth 207 m).
The EtOH extract of the frozen sponge was concentrated and partitioned between H 2 O and n-BuOH. The n-BuOH-soluble materials were further partitioned between n-hexane and aqueous EtOH. The latter fraction was separated by size-exclusion chromatography on a Sephadex LH-20 column to obtain a crude mixture of alkaloids. Separation and purification of these alkaloids were carried out by repeated HPLC to provide pure normonanchocidin A (1), a mixture of normonanchocidins B and D (1:1), and the known monanchocidin A [1] (0.02%, 0.04%, and 0.12%, respectively, based on the dry weight of sponge). Monanchocidin A was structurally identified by comparison of NMR spectra with those reported in the literature [1] . Interpretation of the COSY, HSQC and HMBC data established that the pentacyclic core of 1 ("vessel" part) was identical to that of monanchocidin A and monanchomycalin B, previously found in some collections of Far-Eastern M. pulchra [1, 3] . However, an "anchor" part of compound 1 was not related to either morpholinone or spermidine types. Analysis of the 1 H NMR data of 1 established the absence of a characteristic δ H signal at 4.41 ppm for H-42. Moreover, an upfield shift of proton and carbon signals of the CH-37 group was detected, when compared with the corresponding signal in related pentacycle guanidine compounds. It was suggested that the C-37 atom is located in an acyclic residue, but not in a morpholinone ring, in contrast with other known monanchocidins. Analysis of the NMR data (Table 1 ) and taking into account that the molecular weight of normonanchocidin A (1) is less than that of monanchocidin A by 101 amu, we concluded that its "anchor" part is a derivative of 1,3-diaminopropane (substructure "a", Figure 1 ), which has never before been found in Far-Eastern and tropical pentacyclic guanidine alkaloids [1] [2] [3] [4] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Further analysis of the 1 H NMR data of 1 revealed the presence of branching in the chain fragment, indicated by the triplet for CH 3 at δ H 0.84, similarly to that found earlier in the spectrum of monanchocidin A [1] . Thus, 1 consists of a pentacyclic guanidinium ring system ("vessel part") and an unusual "anchor" part, containing a propylenediamine unit, connected to each other via a branched polymethylene chain, derived from C18 ω-3-hydroxy fatty acid.
Almost complete coincidence of 1 H and 13 C NMR data for the "vessel" part of normonanchocidin A (1) with those of monanchocidins A, D, E [1, 2] and monanchomycalins A and B [3] suggested the same relative configuration for all the chiral carbon atoms in these compounds. On this basis, the 5R*, 8R*, 15S*, and 19S* configurations in the pentacyclic core were proposed.
Therefore, normonanchocidin A (1) is analogous to the known pentacyclic alkaloids, but containing a new type of "anchor" part. [3, 4] and some two-headed sphingolipids [9] . The NMR data showed two variants of the pentacyclic core ( characteristic signals of CH 3 -1, CH 3 -20, H-3, H-5, and H-9. Further interpretation of the NMR data established that the "anchor" part for the two compounds was the same and identical to that of normonanchocidin A. MS and NMR data revealed that the "anchor" and "vessel" parts in 2 and 3 are linked to each other via an unbranched polymethylene chain derived from a C16 ω-hydroxy fatty acid, but not the C18 ω-3-hydroxy fatty acid that was encountered in monanchocidin A [1, 2] and normonanchocidin A (1). Comparison of the 1 H and 13 C NMR data of normonanchocidin B (2) with those of monanchocidin B, and normonanchocidin D (3) with those of monanchocidin D, and their complete coincidence, respectively, suggests the same relative configuration as for 1, monanchocidins A, B and D [1, 2] .
As a result, normonanchocidin B (2) and normonanchocidin D (3) were formulated as new guanidine alkaloids, modified in the "anchor" part in comparison with all other previously known pentacyclic alkaloids from sponges [1] [2] [3] [4] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Based on these data it can be concluded that normonanchocidins A, B and D (1-3) are structural analogues of guanidine pentacyclic alkaloids from the tropical and Far-Eastern marine sponges [1] [2] [3] [4] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , having a new type of "anchor" part.
The cytotoxic activity of the new compounds 1 and the mixture of 2,3 (1:1) against human cancer cells was examined using the MTS test [20] . After 48 h of treatment these alkaloids exhibited IC 50 values of 2.1 µM and 3.7 µM, respectively, against leukemia THP-1 and of 3.8 µM and 6.8 µM, respectively, against cervix epithelial carcinoma HeLa. Therefore, these new compounds were more active than monanchocidin A, previously isolated from the same sponge.
Experimental
General: Optical rotations were measured using a Perkin-Elmer 343 polarimeter. The 1 H and 13 C NMR spectra were recorded on Avance III-700 spectrometers at 700 and 175 MHz, respectively, and chemical shifts were referenced to the corresponding residual solvent signal (δ H 3.30/δ C 49.60 for CD 3 OD, and δ H 2.50/δ C 39.60 for DMSO-d 6 ). ESI mass spectra (including HR ESI-MS) were obtained on an Agilent 6510 Q-TOF LC-MS spectrometer by direct injection in MeOH. Low-pressure column liquid chromatography was performed using Sephadex LH-20 (Sigma Chemical Co.). Si gel plates (4.5×6.0 cm, 5-17 µm, Sorbfil) were used for thinlayer chromatography and compounds were visualized by spraying with 10% H 2 SO 4 solution, followed by heating. HPLC was performed using a Shimadzu Instrument equipped with a differential refractometer RID-10A and a YMC-ODS-A (250×10 mm) column. The Cell Titer 96 Aqueous One Solution Reagent Cell culture: The human cancer cell lines THP-1 (leukemia) and HeLa (cervix epithelial carcinoma) were cultured at 37°C in 5% CO 2 in DMEM medium (Invitrogen, Paisley, UK) containing 10% FBS (HyClone, Cramlington, UK), 2 mM L-glutamine and 1% penicillin/streptomycin (Invitrogen, Paisley, UK). The cell lines were purchased from the ATCC collection.
Cytotoxicity assay (MTS-test):
The effect of the compounds on cell viability was evaluated using the MTS test, which is based on the reduction of MTS into its formazan product by living cells [20] . The experiment was performed as previously described [21, 22] , with slight modifications. Briefly, cells were cultured for 12 h in 96-well plates (6 × 10 3 cells per well), 100 μL/well for HeLa cells and 50 μL/well for THP-1 cells. The medium was then replaced with fresh medium containing substances at various concentrations in a total volume of 100 μL/well (for HeLa cells) or 50 μL/well of fresh substance-containing medium was added (for THP-1 cells) and the cells were incubated for 48 h. Subsequently 20 μL of Cell Titer 96 Aqueous One Solution Reagent was added into each well, and MTS reduction was measured spectrophotometrically 2 h later at 492 and 690 nm as background using Quant equipment (Bio-Tek Instruments, Winooski, VT, USA). Results are represented as IC 50 (inhibition concentration 50%) of the substances.
